AbbVie
ABBV
#25
Rank
A$752.36 B
Marketcap
A$425.64
Share price
-2.33%
Change (1 day)
18.10%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): A$18.62 Billion

According to AbbVie's latest financial reports the company's current earnings are A$66.01 Billion. In 2025 the company made an earning of A$9.81 Billion, an increase over its 2024 earnings that were of A$5.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$18.62 B89.71%
2025 A$9.81 B77.53%
2024 A$5.53 B-40.54%
2023 A$9.30 B-53.62%
2022 A$20.05 B3.76%
2021 A$19.33 B282.25%
2020 A$5.05 B-59.67%
2019 A$12.53 B62.13%
2018 A$7.73 B-32.74%
2017 A$11.49 B-1.99%
2016 A$11.73 B18.65%
2015 A$9.88 B180.5%
2014 A$3.52 B-55.57%
2013 A$7.93 B-6.86%
2012 A$8.51 B56.05%
2011 A$5.45 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.36 B-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$51.74 B 171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.44 B-13.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$0.66 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$3.77 Billion-119.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.86 B-11.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$22.45 B 17.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$10.64 B-44.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.28 B-93.27%๐Ÿ‡บ๐Ÿ‡ธ USA